US2103999A - Disinfective and antiseptic compound for the treatment of ulcers, sores, and the like - Google Patents

Disinfective and antiseptic compound for the treatment of ulcers, sores, and the like Download PDF

Info

Publication number
US2103999A
US2103999A US8164536A US2103999A US 2103999 A US2103999 A US 2103999A US 8164536 A US8164536 A US 8164536A US 2103999 A US2103999 A US 2103999A
Authority
US
Grant status
Grant
Patent type
Prior art keywords
silver
silver oxide
oxide
treatment
contact
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Inventor
Anna L Muller
Co Provident Trust
Original Assignee
Silver Oxide Products Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/922Colloid systems having specified particle size, range, or distribution, e.g. bimodal particle distribution

Description

s PATENT. OFFICE DISINFECTIVE AND ANTISEPTIC COMPOUND son 'rnn TREATMENT or means, scans, AND THE Linn John H. Miiller, Secane, Pa.; Anna L. Muller and Provident Trust 00., executors oi. said John H.

Miller, deceased, assignors to Silver Oxide Products Company, Incorporated, a corpora- UNITED; STATE tion of Pennsylvania No Bra 6 Claims.

This application for Letters Patent is, in part, a continuation of my pending application for Letters Patent, entitled Disinfective and antiseptic compound for the treatment of ulcers,

sores and the like, filed September 27, 1933,

which has received the Serial'Number 691,246, and my invention relates to the preparation of a fluid or semi-fluid compound having a disin- Iective and antiseptic eflect when applied to the Application May 25, 1936, Serial No. 81,645

its mass so that, on coming into contact with the watery fluids of the body; the small particle of silver oxide is rapidly converted into a. solution of silver hydroxide which, while highly eflicient as a disinfectant, acts as such in a quite diiierent 5 v way from that of common silver'oxide applied in more ponderable particles in that it has no tendency to cauterize and injurehealthy tissue and is not liable to bring about any permanent stains 10 treatment of ulcers, sores, abrasions, various skin n e b y to w h t is a p Such Silver 85 10 eruptions or the likeoi': to any more or less inis evolved from my compound in the deoxidation iected surfaces of a human or animal body of the silver oxide passing off with the wastes of whether such surfaces exist in internal or exthebody. s

ternal portions of the body and which can be It is also true, I have found, that the exceedapplied without injury to healthy cellular tissue ingly small particle size oi-the colloidal silver ox 15 and my invention consists in a colloidal suspension and distribution of silver oxide in a nonreactive and inert fluid or semi-fluid vehicle and particularly, and forI believe, the best results, in acolloldal suspension of silver oxide in one of lde enables it to pass through the normal skin of man or animal, or through the pores promptly reaching the more watery tissue and entering the blood stream, no doubt as a hydroxide or other form of ionic silver solution and thus reaching the or a mixture of aliphatic hydrocarbons of infected re ions of th b dvn t rdina a sthev paramn series comprehended within the sible by superficial application of a medicinal general formula Crimn+2- This class of hydrocompound.

carbons is, to a marked degree, nonreactive with My new compound can be conveniently manucolloidal silver oxide. The inactivity of the paraffactured by precipitating silveroxide from an 2 fln hydrocarbons toward silver oxide constitutes aqueous solution of silver nitrate by addition of an important factor in my new remedial coman excess of sodium hydroxide. The precipi-' pound because this very active oxide should extated oxide is filtered and washed upon suction ist in the preparation as such without any chemi. filterswitii distilled water until free from other 6 cal reaction with the fluid or semi-fluid carrier. products of the reaction. The residual mass of It is a matter of chemical knowledge that all or finely divided silver oxide is then freed as far as practically all vehicles of an organic nature canpossible from water by continued suction and is not remain in contact with silver oxide without then'dehydrated in special ovens protectedfrom more or less rapid reduction of the oxide tometai ust or other r d in influences. It is then or formation of complex silver compounds and mixed in known ratio by weight with the non- 35 hence'such mixtures cannot be constrihad as mixreactive hydrocarbon vehicle. This mixture is tures of silver oxide of known composition. then passed through a colloid mill and is in!- In referring to the condition of the silver oxide ther subjected to dispersion in a pebble mill until as colloidal, I mean that the particle size of the requ ed particle size is obtained. This, when 40 oxide distributed through the inert vehicle should carri d out to a suflicient extent, produces a colpredominantly and preferably entirely be of dimensions less than that of a micron and. in practice I have found it, desirable that the particles should predominantly be of dimensions approximating one-half to three-tenths or less of a vehicle so that, on application to a surface the contained silver oxide particles come into contact with the treated surface very shortly after application, and, also because this fine, division 7, of the silver oxide results in giving to each-parti-- cle a relatively enormous surface in relation to loidal suspension of known silver oxide content which can be subsequently diluted with a nonreactive hydrocarbon or hydrocarbon mixtures, (paraflins), of any desired consistency so as to give a final product of any required fluidity and 45 mon use but any desired concentration of the 50,,

colloidal silver oxide can be prepared at the discretion of the physician in the treatment of special cases.' I havefound in practice that to produce a proper colloidal comminution of the silver oxide so that it will contain particles of 55 I contact with the surface until the fluid or semifluid vehicle is practically denuded of the suspended colloidal silver oxide particles and the silver oxide particles coming thus progressively in contact with the treated surface pass into the normal skin or its pores and into contact with the more watery cellular tissue lying beneath it or adjacent to it into direct contact with cellular tissue not protected by the normal skin and/or absorbed into such cellular tissue and thence pass into the blood stream without any caustic action upon the surfaces of tissues treated, such as would tend to injure normal tissue and presumably as a silver hydroxide solution the effect being to act as a disinfectant of not only the immediate surface treated but also adjacent portions of the body not directly accessible, this being accomplished without such liability of bringing about deposits of silver in the treated surface or elsewhere forming permanent discolorizations.

.My new compound, which is a mixture of colloidal silver oxide in an inactive vehicle, takeson a mildly alkaline nature when brought ir i contact with the water invariably present in living tissues. In this way silver oxide mixture is purposely used as a reservoir for production of silver hydroxide, a mild alkaline oxidant which is harmless to normal cellular structures and comparable in alkalinity with blood plasma itself.

It will be understood that the essential feature of my new medicinal compound lies in the com bination of a colloidal subdivision and distribution' of the silver oxide with the inert vehicle which minimizes any tendency to the formation of aggregates of the oxide particles so that, on application, the colloidal particles of silver oxide come progressively into contact with the tissues of the body to which it is applied and are available for rapid absorption thereby, presumably as a silver hydroxide solution, and certainly without any such cauterizing effect upon the tissues treated as is often brought about by the application of the common silver oxide in more ponderant states of subdivision and without danger of bringing about a staining of the skin caused by silver in the reduced condition, such as has been liable to occur on theapplic'ation of other silver compounds.

Having now described my invention, what I claim as new and desire to secure by Letters Patent, is: g

1. The method of preparing a form of silver oxide which will dissolve and form the hydroxide without undergoing substantial reduction to form metallic silver when brought into contact with the human skin, which comprises precipitating silver oxide in an aqueous vehicle, dryingsuch precipitate and then mechanically grinding such oxide. while protected against moisture by an inert, oily, anhydrous vehicle until it has an average particle size of less than onemicron diameter.

2. A method as specified in claim 1, in which the grinding is continued until the average particle size of the silver oxide is less than one-half of a micron.

3. Anhydrous colloidal silver oxide in the form of particles of an average diameter of less than one micron and small enough so that when a thin film of a dispersion of such particles in an inert, oily, anhydrous vehicle is brought into contact with a moist body such as the human skin, the silver particles will migrate to the contact boundary and pass into solution hs silver hydroxide without leaving any substantial surface markin of reduced silver. I

4. Silver oxide as specified in claim 3, in which the average particle size is less than one-half a micron.

5. A dispersion in an inert, anhydrous, oily vehicle of silver oxide; in the form of colloidal particles of average diameter of less than one micron and small enough so that when a thin film of such dispersion is brought into contact with a moist body such as a human skin, the silver particles will migrate to the contact boundary and pass into solution as silver hydroxide without leaving any substantial surface marking of reduced silver.

6. A dispersion as specified in claim 5 in which the inert vehicle is an aliphatic hydrocarbon of the paraffln series.

JOHN H. MULLER.

US2103999A 1936-05-25 1936-05-25 Disinfective and antiseptic compound for the treatment of ulcers, sores, and the like Expired - Lifetime US2103999A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US2103999A US2103999A (en) 1936-05-25 1936-05-25 Disinfective and antiseptic compound for the treatment of ulcers, sores, and the like

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2103999A US2103999A (en) 1936-05-25 1936-05-25 Disinfective and antiseptic compound for the treatment of ulcers, sores, and the like

Publications (1)

Publication Number Publication Date
US2103999A true US2103999A (en) 1937-12-28

Family

ID=22165460

Family Applications (1)

Application Number Title Priority Date Filing Date
US2103999A Expired - Lifetime US2103999A (en) 1936-05-25 1936-05-25 Disinfective and antiseptic compound for the treatment of ulcers, sores, and the like

Country Status (1)

Country Link
US (1) US2103999A (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE963641C (en) * 1948-04-07 1957-05-09 Bristol Lab Inc A process for the preparation of injectable suspensions of penicillin products
WO1995013704A1 (en) * 1993-11-18 1995-05-26 Westaim Technologies Inc. Anti-microbial materials
US5681575A (en) * 1992-05-19 1997-10-28 Westaim Technologies Inc. Anti-microbial coating for medical devices
US5837275A (en) * 1992-05-19 1998-11-17 Westaim Technologies, Inc. Anti-microbial materials
US6299908B1 (en) * 1998-10-06 2001-10-09 Leonie Rosenstiel Compound and method for minimizing the appearance of cutaneous neoplasms and discolorations
US20050199094A1 (en) * 2003-09-09 2005-09-15 Noble Fiber Technologies, Inc. Method of producing metal-containing particles
US20060199752A1 (en) * 2005-02-25 2006-09-07 Tichy Daryl J Aqueous disinfectants and sterilants including transition metals
US20060198876A1 (en) * 2005-02-25 2006-09-07 Tichy Daryl J Aqueous disinfectants and sterilants and related delivery systems
US20060198798A1 (en) * 2005-02-25 2006-09-07 Tichy Daryl J Aqueous disinfectants and sterilants for skin and mucosal application
US20070048175A1 (en) * 2005-02-25 2007-03-01 Tichy Daryl J Methods and compositions for decontaminating surfaces exposed to chemical and/or biological warfare compounds
US20070053850A1 (en) * 2005-02-25 2007-03-08 Tichy Daryl J Aqueous sanitizers, disinfectants, and/or sterilants with low peroxygen content
US20070059255A1 (en) * 2005-02-25 2007-03-15 Tichy Daryl J Methods and compositions for treating disease or injury
US20080000931A1 (en) * 2005-02-25 2008-01-03 Tichy Daryl J Devices, systems, and methods for dispensing disinfectant solutions
WO2008027264A3 (en) * 2006-08-31 2008-05-08 Solutions Biomed Llc Disinfectant systems and methods
US20090232860A1 (en) * 2007-08-30 2009-09-17 Larson Brian G Colloidal metal-containing skin sanitizer
US20100120913A1 (en) * 2008-11-12 2010-05-13 Larson Brian G Resin catalyzed and stabilized peracid compositions and associated methods
US8464910B2 (en) 2008-03-14 2013-06-18 Solutions Biomed, Llc Multi-chamber container system for storing and mixing fluids
US8716339B2 (en) 2008-11-12 2014-05-06 Solutions Biomed, Llc Two-part disinfectant system and related methods
US8789716B2 (en) 2008-11-12 2014-07-29 Solutions Biomed, Llc Multi-chamber container system for storing and mixing liquids

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE963641C (en) * 1948-04-07 1957-05-09 Bristol Lab Inc A process for the preparation of injectable suspensions of penicillin products
US5985308A (en) * 1992-05-19 1999-11-16 Westaim Technologies, Inc. Process for producing anti-microbial effect with complex silver ions
US5681575A (en) * 1992-05-19 1997-10-28 Westaim Technologies Inc. Anti-microbial coating for medical devices
US5753251A (en) * 1992-05-19 1998-05-19 Westaim Technologies, Inc. Anti-microbial coating for medical device
US5770255A (en) * 1992-05-19 1998-06-23 Westaim Technologies, Inc. Anti-microbial coating for medical devices
US5837275A (en) * 1992-05-19 1998-11-17 Westaim Technologies, Inc. Anti-microbial materials
US5958440A (en) * 1992-05-19 1999-09-28 Westaim Technologies, Inc. Anti-microbial materials
US6017553A (en) * 1992-05-19 2000-01-25 Westaim Technologies, Inc. Anti-microbial materials
US6238686B1 (en) 1992-05-19 2001-05-29 Westaim Technologies Anti-microbial coating for medical devices
WO1995013704A1 (en) * 1993-11-18 1995-05-26 Westaim Technologies Inc. Anti-microbial materials
US6299908B1 (en) * 1998-10-06 2001-10-09 Leonie Rosenstiel Compound and method for minimizing the appearance of cutaneous neoplasms and discolorations
US20050199094A1 (en) * 2003-09-09 2005-09-15 Noble Fiber Technologies, Inc. Method of producing metal-containing particles
US8071525B2 (en) 2005-02-25 2011-12-06 Solutions Biomed, Llc Aqueous disinfectants and sterilants including transition metals
US20060198876A1 (en) * 2005-02-25 2006-09-07 Tichy Daryl J Aqueous disinfectants and sterilants and related delivery systems
US20060198798A1 (en) * 2005-02-25 2006-09-07 Tichy Daryl J Aqueous disinfectants and sterilants for skin and mucosal application
US20070048175A1 (en) * 2005-02-25 2007-03-01 Tichy Daryl J Methods and compositions for decontaminating surfaces exposed to chemical and/or biological warfare compounds
US20070053850A1 (en) * 2005-02-25 2007-03-08 Tichy Daryl J Aqueous sanitizers, disinfectants, and/or sterilants with low peroxygen content
US20070059255A1 (en) * 2005-02-25 2007-03-15 Tichy Daryl J Methods and compositions for treating disease or injury
US20080000931A1 (en) * 2005-02-25 2008-01-03 Tichy Daryl J Devices, systems, and methods for dispensing disinfectant solutions
US8802061B2 (en) 2005-02-25 2014-08-12 Solutions Biomed, Llc Aqueous disinfectants and sterilants for skin and mucosal application
US20060199752A1 (en) * 2005-02-25 2006-09-07 Tichy Daryl J Aqueous disinfectants and sterilants including transition metals
US20090004289A1 (en) * 2005-02-25 2009-01-01 Solutions Biomed, Llc Method of disinfecting and providing residual kill at a surface
US7473675B2 (en) 2005-02-25 2009-01-06 Solutions Biomed, Llc Disinfectant systems and methods comprising a peracid, alcohol, and transition metal
US20090053323A1 (en) * 2005-02-25 2009-02-26 Tichy Dary J Aqueous disinfectants and sterilants including transition metals
US7504369B2 (en) 2005-02-25 2009-03-17 Solutions Biomed, Llc Methods and compositions for decontaminating surfaces exposed to chemical and/or biological warfare compounds
US7507701B2 (en) 2005-02-25 2009-03-24 Solutions Biomed, Llc Aqueous disinfectants and sterilants including transition metals
US7511007B2 (en) 2005-02-25 2009-03-31 Solutions Biomed, Llc Aqueous sanitizers, disinfectants, and/or sterilants with low peroxygen content
US7534756B2 (en) 2005-02-25 2009-05-19 Solutions Biomed, Llc Devices, systems, and methods for dispensing disinfectant solutions comprising a peroxygen and transition metal
US7553805B2 (en) 2005-02-25 2009-06-30 Solutions Biomed, Llc Methods and compositions for treating viral, fungal, and bacterial infections
US8084411B2 (en) 2005-02-25 2011-12-27 Solutions Biomed, Llc Method of disinfecting and providing residual kill at a surface
US7462590B2 (en) 2005-02-25 2008-12-09 Solutions Biomed, Llc Aqueous disinfectants and sterilants comprising a peroxide/peracid/transition metal mixture
US7935667B2 (en) 2005-02-25 2011-05-03 Solutions Biomed, Llc Aqueous disinfectants and sterilants including colloidal transition metals
WO2008027264A3 (en) * 2006-08-31 2008-05-08 Solutions Biomed Llc Disinfectant systems and methods
CN101522033B (en) 2006-08-31 2013-11-06 生物医学解决方案公司 Disinfectant systems and methods
US20090232860A1 (en) * 2007-08-30 2009-09-17 Larson Brian G Colloidal metal-containing skin sanitizer
US8464910B2 (en) 2008-03-14 2013-06-18 Solutions Biomed, Llc Multi-chamber container system for storing and mixing fluids
US8716339B2 (en) 2008-11-12 2014-05-06 Solutions Biomed, Llc Two-part disinfectant system and related methods
US8789716B2 (en) 2008-11-12 2014-07-29 Solutions Biomed, Llc Multi-chamber container system for storing and mixing liquids
US20100120913A1 (en) * 2008-11-12 2010-05-13 Larson Brian G Resin catalyzed and stabilized peracid compositions and associated methods
US8987331B2 (en) 2008-11-12 2015-03-24 Solutions Biomed, Llc Two-part disinfectant system and related methods

Similar Documents

Publication Publication Date Title
US3476855A (en) Sterilizing and enhancing activity of a finely divided cartilage powder
US3639574A (en) Stable hydrogen peroxide gels
Gardiner The inhibition of acetylcholine synthesis in brain by a hemicholinium
Rosenthal Experimental Chemotherapy of Burns and Shock I. Methods. II. Effects of Local Therapy upon Mortality from Shock
US3981996A (en) Pharmaceutical skin compositions
Friend et al. Antibiotic effect of tylosin on a mycoplasma contaminant in a tissue culture leukemia cell line.
US1593814A (en) Method for producing a substance adapted to tampon wounds
DENKO et al. The effect of hypophysectomy and growth hormone on S35 fixation in cartilage
US4486450A (en) Method of treating psoriatic skin and composition
US2785153A (en) Silver protein
US3584119A (en) Vaginal douche composition
US5122533A (en) Topical pharmaceutical compositions
US2320479A (en) Topical remedy
Batres et al. Transepithelial elimination of cutaneous chromomycosis
GB2076286A (en) Dermatological hydrogen peroxide compositions
Cameron et al. The toxicity of DDT
US3259545A (en) Stable aluminum hydroxide gel or aluminum hydroxide-sodium zirconium lactate antiperspirant stick
Sebrell et al. Riboflavin deficiency in man: a preliminary note
GB1090421A (en) Improvements in surgical dressings
Ollendick et al. Overcorrection: An overview.
US3198702A (en) Method for treating skin burns
US3356570A (en) Composition for treating shock
US1809082A (en) Product for treating the skin
US3792159A (en) Process for preparing injectionable compositions
US2919230A (en) Hydrophilic base therapeutic compositions comprising cation-exchange resin